Nxera Pharma (SOLTF) Stock Chart & Stock Price History $7.00 0.00 (0.00%) As of 06/13/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Nxera Pharma Stock Price Performance The Nxera Pharma (SOLTF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 30.00%, with a year-to-date return of 13.68%. In the past month, the stock has increased 18.44%, reflecting recent market activity. As of the latest close, Nxera Pharma traded at $7.00 with a market cap of and volume of 0 shares. Five years ago, the stock traded at $14.47, representing a 51.62% decrease over that period. At the time, it had a market cap of and a volume of 35 shares. Receive SOLTF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A5 Year Performance-51.62% SOLTF Stock Chart for Monday, June, 16, 2025 SOLTF Chart by TradingView Nxera Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/05/2025$7.00$7.00$7.00$7.00100 shs$0.0006/04/2025$5.91$7.00+18.44%$7.00$7.00100 shs$0.0005/30/2025$5.91$5.91$5.91$5.901,110 shs$0.0005/29/2025$5.50$5.91+7.45%$5.91$5.901,110 shs$0.0005/28/2025$5.50$5.50$5.50$5.50500 shs$0.0005/27/2025$5.91$5.50-6.94%$5.50$5.50500 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 3SBio Stock Price Chart 60 Degrees Pharmaceuticals Stock Price Chart Abcam Stock Price Chart Agentix Stock Price Chart Algernon Pharmaceuticals Stock Price Chart ALK-Abelló A/S Stock Price Chart Alpha Tau Medical Stock Price Chart Apollomics Stock Price Chart Arno Therapeutics Stock Price Chart Receive SOLTF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:SOLTF) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. Chinese AI chatbot DeepSeek turned the tech world on its hea...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nxera Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nxera Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
